docetaxel anhydrous has been researched along with tetraiodothyroacetic acid in 1 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (tetraiodothyroacetic acid) | Trials (tetraiodothyroacetic acid) | Recent Studies (post-2010) (tetraiodothyroacetic acid) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 122 | 0 | 64 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | tetraiodothyroacetic acid (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.0624 | |
| Integrin alpha-V | Homo sapiens (human) | 0.0624 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, H; Fu, R; Hu, M; Li, C; Li, M; Li, X; Li, Z; Lu, L; Luo, M; Sheng, F; Shi, S; Wu, G; Xiang, M; Xu, J; Zhang, Q; Zhou, M | 1 |
1 other study(ies) available for docetaxel anhydrous and tetraiodothyroacetic acid
| Article | Year |
|---|---|
Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Liberation; Female; Humans; Hyaluronan Receptors; Hyaluronic Acid; Integrin alphaVbeta3; MCF-7 Cells; Mice, Inbred C57BL; Nanoparticles; Neoplasms; Taxoids; Thyroxine; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |